Infection and Immunity · 1983 · 118 citations · 13 references
Life SciencesImmunologyPharmacologyCellular ImmunologyImmunopharmacologyImmunoregulationImmunoglobulin FunctionImmunosuppressionImmunosuppressive AgentsImmunosuppressive TherapyMammalian ImmunologyRodent ImmunologyImmunoglobulin G ResponsesImmunoglobulin ProductionImmunoglobulin QuantificationImmunostimulatory AgentsImmunosuppressive CompoundsImmunosuppressive Function
The metabolites of ochratoxin A, (4R)-4-hydroxyochratoxin A and ochratoxin alpha, were investigated for immunosuppressive properties in BALB/c mice. The standard plaque-counting technique for the estimation of antibody-producing spleen lymphocytes was used. (4R)-4-hydroxyochratoxin A was found to be an immunosuppressor almost as highly effective as ochratoxin A. Doses of 1 microgram of (4R)-4-hydroxyochratoxin A per kg administered to mice caused an 80% reduction in the number of cells producing immunoglobulin M (90% with ochratoxin A) and a 93% reduction in cells synthesizing immunoglobulin G (92% with ochratoxin A). Ochratoxin alpha, however, was ineffective. A possible mode of action is discussed.
13
P. Krogh, B. Hald, R. Pleština et al. · Apmis · 1977 · 112 citations
Medicine, Nephrology, Toxicology +12
Immunosuppression by ochratoxin A and its prevention by phenylalanine
H.-D Haubeck, G Lorkowski, E. Kölsch et al. · Applied and Environmental Microbiology · 1981 · 108 citations · Full text